| Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence RK Vaddepally, P Kharel, R Pandey, R Garje, AB Chandra Cancers 12 (3), 738, 2020 | 1197 | 2020 |
| The future of immunotherapy-based combination therapy in metastatic renal cell carcinoma R Garje, J An, A Greco, RK Vaddepally, Y Zakharia Cancers 12 (1), 143, 2020 | 45 | 2020 |
| Review of immune-related adverse events (irAEs) in non-small-cell lung cancer (NSCLC)—their incidence, management, multiorgan irAEs, and rechallenge R Vaddepally, R Doddamani, S Sodavarapu, NR Madam, R Katkar, ... Biomedicines 10 (4), 790, 2022 | 43 | 2022 |
| PARP inhibitors in prostate and urothelial cancers R Garje, RK Vaddepally, Y Zakharia Frontiers in oncology 10, 114, 2020 | 20 | 2020 |
| Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence. Cancers 2020; 12. doi: doi: 10.3390/cancers12030738.[Epub … RK Vaddepally, P Kharel, R Pandey | 6 | |
| Institutional adherence to National Comprehensive Cancer Network (NCCN) guidelines in neoadjuvant treatment of breast cancer and its correlation to outcomes. RK Vaddepally, A Hejab, HY Ali Journal of Clinical Oncology 36 (30_suppl), 47-47, 2018 | 4 | 2018 |
| Myelodysplastic Syndrome in a Patient With Common Variable Immunodeficiency: A Rare Occurrence NR Mateti, RK Vaddepally, PE Skaria, AB Chandra Cureus 14 (9), 2022 | 3 | 2022 |
| The TIME Trial Network to facilitate rapid clinical trial activation, patient screening, and enrollment in molecularly targeted trials. S OLeary, M Shulman, K Ritt, M Degele, E Protomastro, J Clauson, ... Journal of Clinical Oncology 39 (15_suppl), 1563-1563, 2021 | 2 | 2021 |
| Case Report: A case of immune checkpoint inhibitor therapy in a patient with multiple sclerosis R Vaddepally, S Sodavarapu, A Kutadi, W Taylor, N Kumar F1000Research 9, 1167, 2020 | 1 | 2020 |
| A rare case of follicular lymphoma transformed to a high‐grade B‐cell lymphoma in orbit RK Vaddepally, A Hejab, V Dabak, M Menon Clinical Case Reports 7 (5), 1053, 2019 | 1 | 2019 |
| Unexplained pancytopenia in acute myeloid leukemia treatment D Ezekwudo, O Lupak, R Vaddepally, B Gbadamosi, P Kuriakose Clinical Case Reports 6 (8), 1504-1506, 2018 | 1 | 2018 |
| Impact of single day multidisciplinary clinics on the lead time from diagnosis to initiation of treatment in head and neck cancers. RK Vaddepally, V Damarla, B Singal, J Winn, JD Winegarden, S Narayan, ... Journal of Clinical Oncology 33 (15_suppl), e17523-e17523, 2015 | 1 | 2015 |
| Glioblastoma Multiforme and Papillary Thyroid Carcinoma: Rare Combination of Primary Malignancies RB Katkar, R Vaddepally Journal of the Endocrine Society 5 (Supplement_1), A890-A890, 2021 | | 2021 |
| CNS Prophylaxis in Diffuse Large B-Cell Lymphoma & Its Outcomes-an Institutional Review R Vaddepally, A Adhami, C Siedlecki, P Kuriakose Blood 134, 5348, 2019 | | 2019 |
Rohan GarjeAssociate Professor FIU, Chief of Genitourinary Medical Oncology, Miami cancer InstituteAdresse e-mail validée de uiowa.edu